Invention Grant
- Patent Title: Formulations containing pyridazine compounds
- Patent Title (中): 含哒嗪化合物的制剂
-
Application No.: US13660671Application Date: 2012-10-25
-
Publication No.: US09408845B2Publication Date: 2016-08-09
- Inventor: D. Martin Watterson , Linda Van Eldik , Wenhui Hu
- Applicant: Northwestern University
- Applicant Address: US IL Evanston
- Assignee: Northwestern University
- Current Assignee: Northwestern University
- Current Assignee Address: US IL Evanston
- Agency: Millen White Zelano and Branigan, PC
- Agent John Sopp; Anthony Zelano
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D403/14 ; A61K31/501 ; C07D237/20 ; C07D401/12 ; C07D401/14 ; C07D403/12

Abstract:
The invention relates to chemical compounds, compositions and methods of making and using the same. In particular, the invention provides selected pyridazine compounds of the formula I wherein R1, R4, R5, R6, R7, R8, R9, R12, R13 ET R14 are independently hydrogen, hydroxyl, alkyl, alkenyl, alkynyl, alkylene, alkenylene, alkoxy, alkenyloxy, cycloalkyl, cycloalkenyl, cycloalkynyl, cycloalkoxy, aryl, aryloxy, arylalkoxy, aroyl, heteroaryl, heterocyclic, acyl, acyloxy, amino, imino, azido, thiol, thioallyl, thioalkoxy, thioaryl, nitro, cyano, halo, sulfate, sulfonyl, sulfinyl, sulfonyl, sultanate, sulfoxide, silyl, silyloxy, silylalkyl, silylthio, ═O, ═S, phosphonate, ureido, carboxyl, carbonyl, carbamoyl, or carboxamide; and X is optionally substituted pyrimidinyl or pyridazinyl, an isomer, a pharmaceutically acceptable salt, or derivative thereof. The invention additional relates to compositions comprising the compounds, and methods of using the compounds and compositions for modulation of cellular pathways, for treatment or prevention of inflammatory diseases, for research, drug screening, and therapeutic applications.
Public/Granted literature
- US20130072496A1 FORMULATIONS CONTAINING PYRIDAZINE COMPOUNDS Public/Granted day:2013-03-21
Information query
IPC分类: